First Time Loading...

Insmed Inc
NASDAQ:INSM

Watchlist Manager
Insmed Inc Logo
Insmed Inc
NASDAQ:INSM
Watchlist
Price: 24.92 USD -3.45% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

INSM's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. [ Read More ]

The intrinsic value of one INSM stock under the Base Case scenario is 54.2 USD. Compared to the current market price of 24.92 USD, Insmed Inc is Undervalued by 54%.

Key Points:
INSM Intrinsic Value
Base Case
54.2 USD
Undervaluation 54%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Insmed Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling INSM stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Insmed Inc

Provide an overview of the primary business activities
of Insmed Inc.

What unique competitive advantages
does Insmed Inc hold over its rivals?

What risks and challenges
does Insmed Inc face in the near future?

Has there been any significant insider trading activity
in Insmed Inc recently?

Summarize the latest earnings call
of Insmed Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Insmed Inc.

Provide P/S
for Insmed Inc.

Provide P/E
for Insmed Inc.

Provide P/OCF
for Insmed Inc.

Provide P/FCFE
for Insmed Inc.

Provide P/B
for Insmed Inc.

Provide EV/S
for Insmed Inc.

Provide EV/GP
for Insmed Inc.

Provide EV/EBITDA
for Insmed Inc.

Provide EV/EBIT
for Insmed Inc.

Provide EV/OCF
for Insmed Inc.

Provide EV/FCFF
for Insmed Inc.

Provide EV/IC
for Insmed Inc.

Show me price targets
for Insmed Inc made by professional analysts.

What are the Revenue projections
for Insmed Inc?

How accurate were the past Revenue estimates
for Insmed Inc?

What are the Net Income projections
for Insmed Inc?

How accurate were the past Net Income estimates
for Insmed Inc?

What are the EPS projections
for Insmed Inc?

How accurate were the past EPS estimates
for Insmed Inc?

What are the EBIT projections
for Insmed Inc?

How accurate were the past EBIT estimates
for Insmed Inc?

Compare the revenue forecasts
for Insmed Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Insmed Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Insmed Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Insmed Inc compared to its peers.

Compare the P/E ratios
of Insmed Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Insmed Inc with its peers.

Analyze the financial leverage
of Insmed Inc compared to its main competitors.

Show all profitability ratios
for Insmed Inc.

Provide ROE
for Insmed Inc.

Provide ROA
for Insmed Inc.

Provide ROIC
for Insmed Inc.

Provide ROCE
for Insmed Inc.

Provide Gross Margin
for Insmed Inc.

Provide Operating Margin
for Insmed Inc.

Provide Net Margin
for Insmed Inc.

Provide FCF Margin
for Insmed Inc.

Show all solvency ratios
for Insmed Inc.

Provide D/E Ratio
for Insmed Inc.

Provide D/A Ratio
for Insmed Inc.

Provide Interest Coverage Ratio
for Insmed Inc.

Provide Altman Z-Score Ratio
for Insmed Inc.

Provide Quick Ratio
for Insmed Inc.

Provide Current Ratio
for Insmed Inc.

Provide Cash Ratio
for Insmed Inc.

What is the historical Revenue growth
over the last 5 years for Insmed Inc?

What is the historical Net Income growth
over the last 5 years for Insmed Inc?

What is the current Free Cash Flow
of Insmed Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Insmed Inc.

Financials

Balance Sheet Decomposition
Insmed Inc

Current Assets 929.1m
Cash & Short-Term Investments 780.4m
Receivables 41.2m
Other Current Assets 107.4m
Non-Current Assets 400.8m
PP&E 104.4m
Intangibles 199.8m
Other Non-Current Assets 96.6m
Current Liabilities 225.6m
Accounts Payable 68.7m
Accrued Liabilities 154.3m
Other Current Liabilities 2.6m
Non-Current Liabilities 1.4B
Long-Term Debt 1.2B
Other Non-Current Liabilities 253.8m
Efficiency

Earnings Waterfall
Insmed Inc

Revenue
305.2m USD
Cost of Revenue
-65.6m USD
Gross Profit
239.6m USD
Operating Expenses
-920.6m USD
Operating Income
-680.9m USD
Other Expenses
-68.6m USD
Net Income
-749.6m USD

Free Cash Flow Analysis
Insmed Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

INSM Profitability Score
Profitability Due Diligence

Insmed Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional ROE
Exceptional Revenue Growth Forecast
ROE is Increasing
35/100
Profitability
Score

Insmed Inc's profitability score is 35/100. The higher the profitability score, the more profitable the company is.

INSM Solvency Score
Solvency Due Diligence

Insmed Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Positive Net Debt
Long-Term Solvency
41/100
Solvency
Score

Insmed Inc's solvency score is 41/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

INSM Price Targets Summary
Insmed Inc

Wall Street analysts forecast INSM stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for INSM is 44.74 USD with a low forecast of 35.35 USD and a high forecast of 57.75 USD.

Lowest
Price Target
35.35 USD
42% Upside
Average
Price Target
44.74 USD
80% Upside
Highest
Price Target
57.75 USD
132% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Ownership

INSM Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Shareholder Return

INSM Price
Insmed Inc

1M 1M
-8%
6M 6M
-2%
1Y 1Y
+29%
3Y 3Y
-31%
5Y 5Y
-20%
10Y 10Y
+96%
Annual Price Range
24.92
52w Low
18.38
52w High
31.74
Price Metrics
Average Annual Return -7.5%
Standard Deviation of Annual Returns 33.15%
Max Drawdown -63%
Shares Statistics
Market Capitalization 3.7B USD
Shares Outstanding 148 555 008
Percentage of Shares Shorted 6.18%

INSM Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Insmed Inc Logo
Insmed Inc

Country

United States of America

Industry

Biotechnology

Market Cap

3.7B USD

Dividend Yield

0%

Description

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. The company is headquartered in Bridgewater, New Jersey and currently employs 613 full-time employees. Its clinical-stage pipeline includes brensocatib and treprostinil palmitil inhalation powder (TPIP). Brensocatib is a small molecule, oral, reversible inhibitor of dipeptidyl peptidase 1, which is developing for the treatment of patients with bronchiectasis, cystic fibrosis (CF) and other neutrophil-mediated diseases, including chronic rhinosinusitis without nasal polyps (CRS) and hidradenitis suppurativa (HS). TPIP is an inhaled formulation of the treprostinil prodrug treprostinil palmitil which may offer a differentiated product profile for pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).

Contact

NEW JERSEY
Bridgewater
700 Us Highway 202/206
+19089779900.0
https://insmed.com/

IPO

1991-02-15

Employees

613

Officers

President, CEO & Chairman
Mr. William H. Lewis J.D., M.B.A.
Chief Financial Officer
Ms. Sara M. Bonstein M.B.A.
Chief Operating Officer
Mr. Roger Adsett M.B.A.
Chief Commercial Officer
Mr. John Drayton Wise M.B.A.
Chief Medical Officer
Dr. Martina Flammer M.B.A., M.D.
Chief Scientific Officer
Mr. Brian K. Kaspar Ph.D.
Show More
Associate Director of Investor Relations
Eleanor Barisser
Chief Legal Officer & Corporate Secretary
Mr. Michael Alexander Smith J.D.
Executive Director of Corporate Communications
Mandy Fahey
Chief People Strategy Officer
Ms. S. Nicole Schaeffer M.B.A.
Show Less

See Also

Discover More
What is the Intrinsic Value of one INSM stock?

The intrinsic value of one INSM stock under the Base Case scenario is 54.2 USD.

Is INSM stock undervalued or overvalued?

Compared to the current market price of 24.92 USD, Insmed Inc is Undervalued by 54%.